Is capmatinib (Tabrecta) available in China? Is it easy to buy?

Introduction: Capmatinib (Tabrecta) is an oral drug and a highly selective small molecule inhibitor of cMET. Studies have shown that capmatinib has anti-tumor properties against MET-driven tumors in in vitro and in vivo solid tumor models, with the drug being 30 times more potent than crizotinib.

Is Tabrecta available in China

has been launched in China. On June 12, 2024, Novartis China announced that its non-small cell lung cancer drug capmatinib tablets have been approved by the China National Medical Products Administration for marketing. It can be used for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) carrying mesenchymal epithelial transition factor (MET) exon 14 skipping mutations without systemic treatment. Patients can purchase it in hospitals.

Is Tabrecta easy to buy?

Tabrecta is easier to buy. You can refer to the following purchasing channels.

1. Hospital pharmacies: Capmatinib (Tabrecta) is sold in pharmacies of some large hospitals, and patients can buy it with a prescription in the hospital pharmacies.

2. Officially authorized online pharmacies: Some officially authorized online pharmacies also provide sales services for this drug. Patients can choose pharmacies with formal qualifications and good reputation to purchase.

3. Medical service institutions: If you want to purchase more versions of capmatinib, you can purchase it through domestic medical service institutions.

When purchasing capmatinib, you should choose the appropriate purchasing channel according to your own situation and needs, and pay attention to checking drug information and paying attention to prices.

The price of Tabrecta

varies according to different versions and specifications.

1. Laos Lucius Pharmaceuticals version: The price of the generic version of capmatinib produced by Laos Lucius Pharmaceuticals is about 2600$-3200$ per box, and the specification of a box is 200mgx60 tablets.

2. Bangladesh Everest version: The price of the generic version of capmatinib produced by Bangladesh Everest is about 3600$-4000$ per box, and the specification of a box is 200mg*56 tablets.

The above prices are for reference only. The actual price may vary due to market changes, purchasing channels, exchange rate fluctuations and other factors. When purchasing, patients should choose formal channels and pay attention to verify the authenticity and legality of the drugs.